Michael Kranda

Michael Kranda is an accomplished executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Board Member and Chief Business Officer at Aclipse Therapeutics since May 2023, Kranda previously held leadership roles including Chief Executive Officer and Board Member at LifeSprout, where successful operational turnarounds were achieved. Prior roles encompass Senior Vice President at Asklepios BioPharmaceutical, Senior Director of Business Development at the Allen Institute, and CEO of BEAT BioTherapeutics, among others. Kranda has demonstrated expertise in managing clinical trials, leading strategic initiatives, and driving financial growth, supported by an MBA in Finance from the University of Washington.